Combating breast cancer-associated metastasis using paclitaxel and tranilast-loaded human serum albumin nanoparticles
HSA nanoparticles enhance the delivery and accumulation of hydrophobic drugs (PTX and TRA) in breast cancer cells, offering improved therapeutic outcomes. This combinatorial strategy permits further preclinical investigation for synergistic breast cancer management.
Authors
- Syed Shahrukh
- Giriraj Pandey
- Saurabh Srivastava (ORCID: https://orcid.org/0000-0003-4610-1790)
- Dadi A. Srinivasarao (ORCID: https://orcid.org/0000-0003-1171-0668)
- Prashanth Kumar (ORCID: https://orcid.org/0000-0001-9553-140X)
- Paras Famta
- Naitik Jain (ORCID: https://orcid.org/0009-0004-8387-4949)
- Anamika Sharma (ORCID: https://orcid.org/0000-0002-0054-9904)
- Anjesh Khan
- Swapnil Shinde
- Saurabh Shah (ORCID: https://orcid.org/0009-0008-0873-6377)
- Ganesh Vambhurkar
- Suraj Wagh
Institutions
- National Institute of Pharmaceutical Education and Research - Ahmedabad (IN)
- National Institute of Pharmaceutical Education and Research (IN)
Publication Details
- Journal
- Drug Development and Industrial Pharmacy
- Published
- 2025-05-22
- DOI
- https://doi.org/10.1080/03639045.2025.2509861
- Citations
- 2
- Primary Topic
- Nanoparticle-Based Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 1.19